Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03261050 · ClinicalTrials.gov registry record · NA
Target Engagement of a Novel Dissonance-Based Treatment for DSM-5 Eating Disorders
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 83
- Enrollment target
NCT03261050: Completed NA study, sponsored by Stanford University.
NCT03261050 is a NA study that has completed, run by Stanford University. The registered enrollment target is 83 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03261050, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 83 participants
- Enrollment target
Study Summary
Most people with an eating disorder (ED) do not receive good treatment. The investigators have developed a new brief group treatment that is supposed to work by reducing how much women with an ED value the impossible thinness standard promoted by the media and how much they value/crave binge foods. The investigators want to test whether the treatment actually changes those two mechanisms using brain scan data, which is more objective than completing questionnaires and even interviews. In the first phase of the study (R61), the investigators will compare women in the treatment versus those on a wait-list. If the investigators can show that the treatment "works" (does what the investigators think it does) compared to no active treatment (women will be allowed to seek and receive outside help but investigators will not provide it until after the wait-list), investigators will conduct the second phase of study (R33),where they will randomly assign women with an ED to either the new treatment or to a group treatment that represents what many college mental health clinics provide to their clients with ED.
Interventions
- BEHAVIORAL Interpersonal Therapy
- BEHAVIORAL Counter Attitudinal Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2017-07-10 |
| Est. Completion | 2025-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03261050
The ClinicalTrials.gov registry entry for NCT03261050 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 83 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Interpersonal Therapy is the first listed.
NCT03261050 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03261050 about?
NCT03261050 is a clinical study titled "Target Engagement of a Novel Dissonance-Based Treatment for DSM-5 Eating Disorders". Most people with an eating disorder (ED) do not receive good treatment. The investigators have developed a new brief group treatment that is supposed to work by reducing how much women with an ED value the impossible thinness standard promoted by the media and how much they value/crave binge foods. ...
What is the current status of trial NCT03261050?
This trial is currently completed. It is a NA study. The enrollment target is 83 participants. The study started on 2017-07-10. Estimated completion is 2025-01-31.
What interventions are being tested in trial NCT03261050?
The interventions under investigation include: Interpersonal Therapy (BEHAVIORAL), Counter Attitudinal Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT03261050?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.